Changes in the Type 2 diabetes gut mycobiome associate with metformin treatment across populations
E. Van Syoc, M. P. Nixon, J. D. Silverman, Y. Luo, F. J. Gonzalez, I. Elbere, J. Klovins, A. D. Patterson, C. J. Rogers, E. Ganda
This study identifies metformin and T2D as factors influencing gut fungal communities across human populations.
bioRxiv · May 25, 2023 · PreprintMicrobiology